Financials data is unavailable for this security.
View more
Year on year Yifeng Pharmacy Chain Co Ltd grew revenues 13.59% from 19.89bn to 22.59bn while net income improved 11.57% from 1.27bn to 1.41bn.
| Gross margin | 38.47% |
|---|---|
| Net profit margin | 6.90% |
| Operating margin | 9.08% |
| Return on assets | 6.72% |
|---|---|
| Return on equity | 15.51% |
| Return on investment | 12.76% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Yifeng Pharmacy Chain Co Ltd fell by 449.62m. However, the company earned 4.62bn from its operations for a Cash Flow Margin of 20.47%. In addition the company used 2.98bn on investing activities and also paid 2.09bn in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 8.46 |
|---|---|
| Tangible book value per share | 4.10 |
More ▼
Balance sheet in CNYView more
| Current ratio | 1.19 |
|---|---|
| Quick ratio | 0.8771 |
| Total debt/total equity | 1.17 |
|---|---|
| Total debt/total capital | 0.5237 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 75.01% and 11.07%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Retail (Drugs) industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked the highest relative to its industry peers.
| Div yield(5 year avg) | 0.63% |
|---|---|
| Div growth rate (5 year) | 33.54% |
| Payout ratio (TTM) | 33.17% |
| EPS growth(5 years) | 25.49 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 6.06 |
More ▼
